Open Access Policy

The Clinical Medicine and Pharmacology (CMP) is dedicated to promoting the broadest possible dissemination of research by providing immediate and unrestricted access to all published content. As a fully open-access journal, CMP adheres to the following principles:

Unrestricted Access

  • All content published in CMP is freely accessible online without charge to readers or their institutions.
  • Users are permitted to:
    • Read, download, copy, distribute, print, search, or link to the full texts of articles.
    • Use the content for any lawful purpose, without the need for prior permission from the publisher or authors, provided proper attribution is given.

No Embargo Period

  • CMP follows a no-embargo policy, ensuring all articles are available for free and open access immediately upon publication.

No Registration Requirement

  • Readers do not need to register or log in to access the journal’s content. All articles are openly available without barriers.

Licensing and Copyright

  • Articles are published under the Creative Commons Attribution 4.0 International (CC BY 4.0) license.
  • This license permits unrestricted reuse, distribution, and adaptation of content, as long as proper credit is given to the original authors and source.

Benefits of Open Access

  • For Authors : Authors retain copyright to their work and gain increased visibility, impact, and citation of their research.
  • For Readers : Researchers, students, and the public worldwide have free access to high-quality, peer-reviewed content without financial or technical restrictions.

Commitment to Open Science

  • CMP upholds the principles of open science, fostering a collaborative and inclusive global research environment. By removing barriers to access, we aim to advance knowledge-sharing and innovation in the field of social sciences.

For further information on our open access policy, please contact us at contact@press.jandoo.ac .